🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚗 Are Driving Restrictions After CAR-T Therapy Too Long? 🧬 New study in Blood Advances led by Dr. Rahul Banerjee & Dr. Gurbakhash Kaur challenges the 8-week driving restriction for patients receiving CAR-T therapy for multiple myeloma (MM). Researchers analyzed 586 patients

Now playing… One of my favorites from the Kings.

Live from the Fred Hutch Cancer Center UW Medicine Hematology and Oncology Research Retreat! Excellent talk from Dr. Emily Liang presenting our prophylactic anakinra trial to prevent toxicities associated with liso-cel in LBCL patients.

🙏😊 Fred Hutch Cancer Center

Wonderful piece on how to become a better writer. « A rule of thumb is that your drafts should get shorter with each iteration. Don’t write for the Nobel laureates in your field. Write for the students — and your parents, because they want to read your writing more badly than

Well deserved Filippo Milano MD, PhD ! An outstanding investigator, physician and a great friend!

🚨 5-year follow-up from a phase 1 trial of FCARH143, a fully human anti-BCMA CAR-T for relapsed/refractory #MultipleMyeloma 🔬 Let’s dive into the results from this study conducted at Fred Hutch Cancer Center & UW Medicine 🧵

Book recommendations from patient 👌 #whenonservice

"Every intellectual has a very special responsibility. He has the privilege and the opportunity of studying. In return, he owes it to his fellow men (or ‘to society’) to represent the results of his study as simply, clearly and modestly as he can. The worst thing that

Exciting to listen to the great David Baker University of Washington at the Fred Hutch Cancer Center TST retreat today! Fascinating to learn more about how novel proteins are designed using deep learning (diffusion process). Staggering breadth of potential clinical applications: - anti-toxins - anti-inflammatory -

😢

Just a few months ago, the Baker and Garcia labs released con-concurrent preprints with incredible results. They designed de novo miniproteins that bound specific peptides presented in MHC-I. Now let me show how you can use BindCraft at Ariax Bio to do the same thing.

👀

Save the date for our next Seattle Cellular Therapy Summit. Outstanding line of speakers and great topics. Krish Patel Binaytara Fred Hutch Cancer Center #SeattleCT25 urldefense.com/v3/__https://d…$

🔬 Science Spotlight at Fred Hutch Cancer Center: A real-world, 3-year analysis compares axi-cel & liso-cel for relapsed LBCL. Both CAR-T therapies were equally effective, but liso-cel had less CRS, ICANS, & supportive care. 🔗fredhutch.org/en/news/spotli… 📄haematologica.org/article/view/1… Jordan Gauthier

Delighted to share our manuscript from The Lancet Haematology Commission on Adverse Events We focus on optimising assessment of toxicity and tolerability in patients receiving novel therapies Led by the fab Paul Bröckelmann thelancet.com/journals/lanha… #lymsm Florian Simon Gloria Iacoboni

Dr. Andrew Portuguese et al ruling the Fred Hutch Cancer Center courtyard stage!